Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 14, 2014; 20(30): 10405-10418
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10405
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10405
Pancreatic cancer-improved care achievable
Trond A Buanes, Division of Cancer, Surgery and Transplantation, Institute of Clinical Medicine, Faculty of Medicine, Oslo University Hospital (OuS), University of Oslo, 0316 Oslo, Norway
Trond A Buanes, Department of Gastroenterological Surgery, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, 0316 Oslo, Norway
Author contributions: Buanes TA contributed to the manuscript.
Correspondence to: Trond A Buanes, MD, PhD, Professor of Surgery, Division of Cancer, Surgery and Transplantation, Institute of Clinical Medicine, Faculty of Medicine, Oslo University Hospital (OuS), University of Oslo, P.O. Box 1072 Blindern, 0316 Oslo, Norway. trond.buanes@medisin.uio.no
Telephone: +47-230-70958 Fax: +47-911-82938
Received: October 17, 2013
Revised: January 16, 2014
Accepted: April 30, 2014
Published online: August 14, 2014
Processing time: 304 Days and 17.9 Hours
Revised: January 16, 2014
Accepted: April 30, 2014
Published online: August 14, 2014
Processing time: 304 Days and 17.9 Hours
Core Tip
Core tip: Curative treatment outcome for patients with pancreatic cancer is achievable if early surgical treatment is combined with adjuvant chemotherapy. Nevertheless, most patients end up in a palliative situation, earlier or later. Also palliative therapeutic interventions are improving, but a multidisciplinary team with advanced expertise is a prerequisite for optimal care.